{"id":"https://openalex.org/W2275987487","doi":"https://doi.org/10.1016/j.coviro.2016.01.013","title":"HSV antivirals \u2013 current and future treatment options","display_name":"HSV antivirals \u2013 current and future treatment options","publication_year":2016,"publication_date":"2016-02-19","ids":{"openalex":"https://openalex.org/W2275987487","doi":"https://doi.org/10.1016/j.coviro.2016.01.013","mag":"2275987487","pmid":"https://pubmed.ncbi.nlm.nih.gov/26897058"},"language":"en","primary_location":{"id":"doi:10.1016/j.coviro.2016.01.013","doi":"https://doi.org/10.1016/j.coviro.2016.01.013","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.coviro.2016.01.013","pdf_url":null,"source":{"id":"https://openalex.org/S2489902859","display_name":"Current Opinion in Virology","issn_l":"1879-6257","issn":["1879-6257","1879-6265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Virology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005777715","display_name":"Alexander Birkmann","orcid":"https://orcid.org/0000-0001-5670-4814","observed_orcids":["https://orcid.org/0000-0001-5670-4814"]},"institutions":[{"id":"https://openalex.org/I4210157949","display_name":"AiCuris (Germany)","ror":"https://ror.org/048jsd987","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210157949"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Alexander Birkmann","raw_affiliation_strings":["AiCuris Anti-infective Cures GmbH, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AiCuris Anti-infective Cures GmbH, Germany","institution_ids":["https://openalex.org/I4210157949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004728480","display_name":"Holger Zimmermann","orcid":"https://orcid.org/0000-0002-7919-4447","observed_orcids":["https://orcid.org/0000-0002-7919-4447"]},"institutions":[{"id":"https://openalex.org/I4210157949","display_name":"AiCuris (Germany)","ror":"https://ror.org/048jsd987","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210157949"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Holger Zimmermann","raw_affiliation_strings":["AiCuris Anti-infective Cures GmbH, Germany. Electronic address: holger.zimmermann@aicuris.com","AiCuris Anti-infective Cures GmbH, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AiCuris Anti-infective Cures GmbH, Germany. Electronic address: holger.zimmermann@aicuris.com","institution_ids":["https://openalex.org/I4210157949"]},{"raw_affiliation_string":"AiCuris Anti-infective Cures GmbH, Germany","institution_ids":["https://openalex.org/I4210157949"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5004728480"],"corresponding_institution_ids":["https://openalex.org/I4210157949"],"apc_list":{"value":3690,"currency":"USD","value_usd":3690},"apc_paid":null,"fwci":1.7194,"has_fulltext":false,"cited_by_count":116,"citation_normalized_percentile":{"value":0.85176125,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"18","issue":null,"first_page":"9","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/herpes-simplex-virus","display_name":"herpes simplex virus","score":0.9480000138282776},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-1","display_name":"herpes simplex virus type 1","score":0.8149999976158142},{"id":"https://openalex.org/keywords/herpes-simplex-virus-type-2","display_name":"herpes simplex virus type 2","score":1.0},{"id":"https://openalex.org/keywords/antiviral-therapy","display_name":"antiviral therapy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.9879999756813049},{"id":"https://openalex.org/keywords/therapeutic-vaccines","display_name":"therapeutic vaccines","score":0.9079999923706055},{"id":"https://openalex.org/keywords/amenamevir","display_name":"amenamevir","score":0.8109999895095825},{"id":"https://openalex.org/keywords/pritelivir","display_name":"pritelivir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/helicase-primase-inhibitors","display_name":"helicase-primase inhibitor","score":0.9890000224113464},{"id":"https://openalex.org/keywords/genital-herpes","display_name":"genital herpes","score":0.9490000009536743},{"id":"https://openalex.org/keywords/herpes-labialis","display_name":"oral herpes","score":0.6690000295639038},{"id":"https://openalex.org/keywords/small-molecule-antivirals","display_name":"small-molecule antivirals","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.6944583058357239},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.634533166885376},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.43367132544517517},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3962249159812927},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38250112533569336},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3051415681838989},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22209173440933228}],"mesh":[{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004265","descriptor_name":"DNA Helicases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D006558","descriptor_name":"Herpes Genitalis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006558","descriptor_name":"Herpes Genitalis","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D006561","descriptor_name":"Herpes Simplex","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006561","descriptor_name":"Herpes Simplex","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006561","descriptor_name":"Herpes Simplex","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010069","descriptor_name":"Oxadiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010069","descriptor_name":"Oxadiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014764","descriptor_name":"Viral Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018258","descriptor_name":"Herpesvirus 2, Human","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018259","descriptor_name":"Herpesvirus 1, Human","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019915","descriptor_name":"DNA Primase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D022301","descriptor_name":"Herpes Simplex Virus Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D022301","descriptor_name":"Herpes Simplex Virus Vaccines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D022301","descriptor_name":"Herpes Simplex Virus Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.coviro.2016.01.013","doi":"https://doi.org/10.1016/j.coviro.2016.01.013","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.coviro.2016.01.013","pdf_url":null,"source":{"id":"https://openalex.org/S2489902859","display_name":"Current Opinion in Virology","issn_l":"1879-6257","issn":["1879-6257","1879-6265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Opinion in Virology","raw_type":"journal-article"},{"id":"pmid:26897058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26897058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in virology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1964985694","https://openalex.org/W1969870818","https://openalex.org/W1996022677","https://openalex.org/W1997862513","https://openalex.org/W2004259033","https://openalex.org/W2011006965","https://openalex.org/W2019405166","https://openalex.org/W2029281897","https://openalex.org/W2029735979","https://openalex.org/W2036872389","https://openalex.org/W2043841254","https://openalex.org/W2064587156","https://openalex.org/W2070423053","https://openalex.org/W2075703351","https://openalex.org/W2083083619","https://openalex.org/W2098084846","https://openalex.org/W2102715326","https://openalex.org/W2130145455","https://openalex.org/W2131590075","https://openalex.org/W2137186878","https://openalex.org/W2139835084","https://openalex.org/W2140811217","https://openalex.org/W2148365504","https://openalex.org/W2159240184","https://openalex.org/W2168752866","https://openalex.org/W2198528112","https://openalex.org/W2272791893","https://openalex.org/W2337832644","https://openalex.org/W2610208464","https://openalex.org/W4233562659"],"related_works":["https://openalex.org/W2055927452","https://openalex.org/W2029925693","https://openalex.org/W2028460611","https://openalex.org/W1997862513","https://openalex.org/W2081007549","https://openalex.org/W4406682575","https://openalex.org/W3005801668","https://openalex.org/W28433492","https://openalex.org/W2337832644","https://openalex.org/W2032426565"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}